Current clinical management of acute myocardial infarction complicated by cardiogenic shock

References

• Kolte D, Khera S, Aronow WS, et al. Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States. J Am Heart Assoc. 2014;3(1):e000590.
   PubMed Web of Science ®Google Scholar
• Goldberg RJ, Spencer FA, Gore JM, et al. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation. 2009;119(9):1211–1219.
   PubMed Web of Science ®Google Scholar
• Zeymer U, Bueno H, Granger CB, et al. Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: a document of the Acute Cardiovascular Care Association of the European Society of Cardiology. Eur Heart J Acute Cardiovasc Care. 2020;9(2):183–197.
   PubMed Web of Science ®Google Scholar
• Aissaoui N, Puymirat E, Tabone X, et al. Improved outcome of cardiogenic shock at the acute stage of myocardial infarction: a report from the USIK 1995, USIC 2000, and FAST-MI French nationwide registries. Eur Heart J. 2012;33(20):2535–2543.
   PubMed Web of Science ®Google Scholar
• Harjola VP, Lassus J, Sionis A, et al. CardShock study investigators; GREAT network. Clinical picture and risk prediction of short-term mortality in cardiogenic shock. Eur J Heart Fail. 2015;17(5):501–509.
   PubMed Web of Science ®Google Scholar
• Pöss J, Köster J, Fuernau G, et al. Risk stratification for patients in cardiogenic shock after acute myocardial Infarction. J Am Coll Cardiol. 2017;69(15):1913–1920.
   PubMed Web of Science ®Google Scholar
• Lasarte MR, Roselló JS, Lledó EC, et al. External validation and comparison of the CardShock and IABP-SHOCK II risk scores in real-world cardiogenic shock patients. Eur Heart J Acute Cardiovasc Care. 2020;6:2048872619895230.
   Web of Science ®Google Scholar
• Baran DA, Grines CL, Bailey S, et al. SCAI clinical expert consensus statement on the classification of cardiogenic shock: this document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS). Catheter Cardiovasc Inter. 2019;94(1):29–37.
   Google Scholar
• Bangalore S, Gupta N, Guo Y, et al. Outcomes with invasive vs conservative management of cardiogenic shock complicating acute myocardial infarction. Am J Med. 2015;128(6):601–608.
   PubMed Web of Science ®Google Scholar
• Scholz KH, Maier SKG, Maier LS, et al. Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial. Eur Heart J. 2018;39(13):1065–1074.
   PubMed Web of Science ®Google Scholar
• Ibanez B, James S, Agewall S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119.
   PubMed Web of Science ®Google Scholar
• Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med. 1999;341(9):625–634.
   PubMed Web of Science ®Google Scholar
• Hochman JS, Sleeper LA, Webb JG, et al. SHOCK investigators. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA. 2006;295(21):2511–2515.
   PubMed Web of Science ®Google Scholar
• Zeymer U, Hochadel M, Karcher AK, et al. Procedural success rates and mortality in elderly patients with percutaneous coronary intervention for cardiogenic shock. JACC Cardiovasc Interv. 2019;12(18):1853–1859.
   PubMed Web of Science ®Google Scholar
• Thiele H, Akin I, Sandri M, et al. CULPRIT-SHOCK investigators. PCI strategies in patients with acute myocardial infarction and cardiogenic shock. N Engl J Med. 2017;377(25):2419–2432.
   PubMed Web of Science ®Google Scholar
• Thiele H, Akin I, Sandri M, et al., CULPRIT-SHOCK investigators. One-year outcomes after PCI strategies in cardiogenic shock. N Engl J Med. 379(18): 1699. 2018.
   PubMed Web of Science ®Google Scholar
• Neumann FJ, Sousa Uva M, Ahlsson A, et al. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87–165.
   PubMed Web of Science ®Google Scholar
• Kantrowitz A, Tjonneland S, Freed PS, et al. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA. 1968;203(2):113–118.
   PubMed Web of Science ®Google Scholar
• Thiele H, Zeymer U, Neumann FJ, et al., IABP-SHOCK II trial investigators. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 367(14): 1287–1296. 2012.
   PubMed Web of Science ®Google Scholar
• Thiele H, Zeymer U, Neumann FJ, et al. Intraaortic balloon pump in cardiogenic shock II (IABP-SHOCK II) trial investigators. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet. 2013;382(9905):1638–1645.
   PubMed Web of Science ®Google Scholar
• Thiele H, Zeymer U, Thelemann N, et al. IABPSHOCK II trial (intraaortic balloon pump in cardiogenic shock ii) investigators. Circulation. 2019;139(3):395.
   PubMed Web of Science ®Google Scholar
• Unverzagt S, Buerke M, Waha AD, et al. Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock. Cochrane Database Syst Re. 2015;2015(3):CD007398
   Google Scholar
• O’Gara PT, Kushner FG, Ascheim DD, et al. American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013;127:529–555.
   Google Scholar
• Cheng JM, den Uil CA, Hoeks SE, et al. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J. 2009;30(17):2102–2108.
   PubMed Web of Science ®Google Scholar
• Werdan K, Gielen S, Ebelt H, et al. Mechanical circulatory support in cardiogenic shock. Eur Heart J. 2014;35(3):156–167.
   PubMed Web of Science ®Google Scholar
• Ouweneel DM, Eriksen E, Sjauw KD, et al. Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol. 2017;69(3):278–287.
   PubMed Web of Science ®Google Scholar
• Seyfarth M, Sibbing D, Bauer I, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008;52(19):1584–1588.
   PubMed Web of Science ®Google Scholar
• Lauten A, Engström AE, Jung C, et al. Percutaneous left-ventricular support with the impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry. Circ Heart Fail. 2013;6(1):23–30.
   PubMed Web of Science ®Google Scholar
• Thiele H, Sick P, Boudriot E, et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005;26(13):1276–1283.
   PubMed Web of Science ®Google Scholar
• Thiele H, Jobs A, Ouweneel DM, et al., Percutaneous short-term active mechanical support devices in cardiogenic shock: a systematic review and collaborative meta-analysis of randomized trials. Eur Heart J. 38(47): 3523–3531. 2017.
   PubMed Web of Science ®Google Scholar
• Anderson MB, Goldstein J, Milano C, et al. Benefits of a novel percutaneous ventricular assist device for right heart failure: the prospective RECOVER RIGHT study of the Impella RP device. J Heart Lung Transplant. 2015;34(12):1549–1560.
   PubMed Web of Science ®Google Scholar
• Zeymer U, Thiele H. Mechanical support for cardiogenic shock: lost in translation? J Am Coll Cardiol. 2017;69(3):288–290.
   PubMed Web of Science ®Google Scholar